Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment With Disease‐modifying Drugs for People With a First Clinical Attack Suggestive of Multiple Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432702/all/Treatment_with_disease‐modifying_drugs_for_people_with_a_first_clinical_attack_suggestive_of_multiple_sclerosis.
Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432702/all/Treatment_with_disease‐modifying_drugs_for_people_with_a_first_clinical_attack_suggestive_of_multiple_sclerosis. Accessed December 8, 2024.
Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432702/all/Treatment_with_disease‐modifying_drugs_for_people_with_a_first_clinical_attack_suggestive_of_multiple_sclerosis
Treatment With Disease‐modifying Drugs for People With a First Clinical Attack Suggestive of Multiple Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432702/all/Treatment_with_disease‐modifying_drugs_for_people_with_a_first_clinical_attack_suggestive_of_multiple_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
ID - 432702
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432702/all/Treatment_with_disease‐modifying_drugs_for_people_with_a_first_clinical_attack_suggestive_of_multiple_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -